Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Does chemotherapy given directly to the liver improve survival in patients with hepatic metastasis?

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1

    Kerr DJ et al. (2003) Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial. Lancet 361: 368–373

    CAS  Article  Google Scholar 

  2. 2

    Hurwitz H et al. (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350: 2335–2342

    CAS  Article  Google Scholar 

  3. 3

    Grothey A et al. (2004) Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-FA, irinotecan and oxaliplatin in the course of treatment. J Clin Oncol 22: 1209–1214

    CAS  Article  Google Scholar 

  4. 4

    Kemeny N et al. (2005) Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer. J Clin Oncol 23: 4888–4896

    CAS  Article  Google Scholar 

Download references


The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.

Author information



Corresponding author

Correspondence to David J Kerr.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kerr, D. Does chemotherapy given directly to the liver improve survival in patients with hepatic metastasis?. Nat Rev Clin Oncol 3, 480–481 (2006).

Download citation


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing